Attune is developing a new class of wearable neurotechnology designed to engage the deep brain safely and non-invasively.
Join our study to help advance sleep and recovery research.
Sleep problems are common among people recovering from opioid use disorder (OUD). Poor sleep can make recovery harder, affecting mood, health, and overall quality of life.
At Attune Neurosciences, we’re developing a first-of-its-kind head-worn device that uses gentle, non-invasive technology to monitor brain activity during sleep. Our goal is to better understand sleep patterns in recovery and design safer, more effective tools to support lasting wellness.
We are currently enrolling participants in Baltimore, Maryland for a short research study to evaluate the comfort and usability of this investigational sleep-monitoring device.
-
Participants must be:Participants must be:
Between 18 and 65 years old
In recovery from opioid use disorder (OUD)
Able to sleep with a soft headband-style device for several nights
Able to attend two visits at the study location in Baltimore
Able to receive and respond to daily text messages on a smartphone with an active data plan
You may not be eligible if you:Have an uncontrolled medical or psychiatric condition other than OUD
Are pregnant, attempting to become pregnant, or nursing
Have skin sensitivities on the head or scalp that make wearing a device uncomfortable
Are unable to complete the required daily questionnaires
What Participation Involves
Participation lasts about one week and includes:A baseline visit to learn about the study and be fitted for the headband device
Nightly use of the device at home while you sleep for seven days
Daily short questionnaires delivered via text message
An exit visit and interview to share feedback on comfort and usability
Participants who complete the study will receive up to $275 in compensation, which includes daily payments and a completion bonus.Important Information
The study device is investigational and not yet FDA-approved. This study does not involve medical treatment — it is focused on assessing comfort, usability, and design feedback.
All information you provide will be kept strictly confidential and protected under a Certificate of Confidentiality from the National Institutes of Health (NIH).
This study has been reviewed and approved by Advarra Institutional Review Board (IRB).Location
REACH IBR
2104 Maryland Ave
Baltimore, MD 21218
Ready to Participate?
Take a brief survey to see if you qualify for this study.